What Does “Health Insurance Cost” Mean?

Beginning next year, people without health insurance through their employer will be able to buy it monthly on “exchanges.” They are encouraged to buy the insurance, or else face a penalty for each month and family member not covered. Let’s suppose for the moment that the penalty is enforced (even though law limits how the IRS can enforce it).

By law, people can let their insurance lapse for three months with no penalty. Moreover, they can choose when the three month lapse occurs, and accelerate and/or delay medical procedures to fall outside the lapse interval, without concern for being denied when they restart insurance because of “pre-existing conditions.”

Arguably, essentially everyone without employer health insurance would find it in his interest to purchase insurance for only 9 months per year, and cram all of their medical procedures into the nine months of their choosing. Medicaid already experiences this phenomenon (namely people enroll if and when they get sick), and Medicaid participants do not pay premiums. Exchange participants will be paying really money.

There is no free lunch in the aggregate, so insurance companies will have to increase their monthly premiums by 12/9 so that they collect the same annual revenue from participants. When this happens, do we say that health insurance costs went up by 33 percent? Or that they were constant?

If you chose the latter, then you are saying that health insurance costs should be measured by premiums per person, where “persons” denominator includes people who are not currently insured. But then the historical trend for health insurance costs should be measured the same way, and would be less steep due to the fact that uninsurance rates have increased over time.

Another problem with choosing the latter is that exchange participants (suckers?) who do not play this game — they pay their premium all 12 months of the year — will pay more for health insurance on both a monthly and an annual basis.

Both proponents and opponents of the ACA will want to know whether the new law fulfilled its promise of “bending the cost curve,” but my guess is that an army of economists will be needed merely to do the measurement — to measure health insurance costs before and after 1/1/2014 in ways that are comparable.

About Casey B. Mulligan 76 Articles

Affiliation: University of Chicago

Casey B. Mulligan is a Professor in the Department of Economics. Mulligan first joined the University of Chicago in 1991 as a graduate student, and received his Ph.D. in Economics from the University of Chicago in 1993.

He has also served as a Visiting Professor teaching public economics at Harvard University, Clemson University, and Irving B. Harris Graduate School of Public Policy Studies at the University of Chicago.

Mulligan is author of the 1997 book Parental Priorities and Economic Inequality, which studies economic models of, and statistical evidence on, the intergenerational transmission of economic status. His recent research is concerned with capital and labor taxation, with particular emphasis on tax incidence and positive theories of public policy. His recent work includes Market Responses to the Panic of 2008 (a book-in-process with Chicago graduate student Luke Threinen) and published articles such as “Selection, Investment, and Women’s Relative Wages,” “Deadweight Costs and the Size of Government,” “Do Democracies have Different Public Policies than Nondemocracies?,” “The Extent of the Market and the Supply of Regulation,” “What do Aggregate Consumption Euler Equations Say about the Capital Income Tax Burden?,” and “Public Policies as Specification Errors.” Mulligan has reported on some of these results in the Chicago Tribune, the Chicago Sun-Times, the Wall Street Journal, and the New York Times.

He is affiliated with a number of professional organizations, including the National Bureau of Economic Research, the George J. Stigler Center for the Study of the Economy and the State, and the Population Research Center. He is also the recipient of numerous awards and fellowships, including those from the National Science Foundation, the Alfred P. Sloan Foundation, the Smith- Richardson Foundation, and the John M. Olin Foundation.

Visit: Supply and Demand (in that order)

Be the first to comment

Leave a Reply

Your email address will not be published.


*